That is necessary, because the way a protein in the body folds figures out if a pharmaceutical will have the ability to bind to that protein and be efficient. To put it simply, we have to know how these proteins fold if we want a drug to work. Historically, this has actually been a trial-and-error process (the legacy report predictions). Now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it much simpler to develop drugs that do what they're created to do. This was a breakthrough practically nobody observed. However it's going to have extensive ramifications for treating illness. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021.
And, naturally, there will be a lot of investment opportunities in this area, too. Shifting topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (tech stock). That said, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be surprised if it drew back maybe significantly prior to going higher - jeff brown 2021 stock predictions. I have actually been covering bitcoin for a very long time now. One of the first research reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial suggestion, I entitled my report "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time. We were mostly informing readers. But that's not the big concern anymore. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. Mass, Mutual is a trusted 170-year-old institution. So think of that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a big reason I'm bullish on it this year. jeff brown 1 biotech. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These business raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I forecast 2021 will be another record year in IPOs. There are a lot of excellent private business on the brink of striking the general public markets And I have actually been working on a brand-new method for you to invest even prior to these companies go public.
This opportunity has actually been constructing over the last few years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to learn all the details. Go right here to reserve your area free of charge.
Emma Walsh here, handling editor of the Journal. Routine Journal readers understand that tech isn't our usual beat (united arab emirates). And when it pertains to tech investing, we leave it to the experts. Fortunately, we have several such professionals in our Rolodex. Our colleague Jeff Brown will be familiar to our longtime readers. He is among the most accomplished tech investing experts we understand (genetic sequencer stock jeff brown). In reality, he had a number of triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take an appearance at the big photo and predict what's just around the corner.
That consists of things like 5G networks, biotech, artificial intelligence, and a lot more. These patterns are experiencing exponential growth and creating amazing opportunities for financiers. I wish to make sure all our readers are gotten ready for what's next. And with that in mind, let me draw the photo of what I see can be found in the next 12 months Our new 5G (fifth-generation) cordless networks are a topic I have actually been covering for years now. genetic sequencer stock jeff brown. But despite what lots of readers might think, this is a trend that's simply beginning. Despite the fact that the COVID-19 pandemic interrupted supply chains in 2015, an excellent 250 million 5G-enabled gadgets were still sold.
And all of this eventually resulted in Apple postponing the release of the 5G-enabled i, Phone 12 by two months (jeff brown top biotech 2020). Losing 2 months of manufacturing and sales truly affects the number of 5G devices are offered in the calendar year. When you consider all of that, offering 250 million units is exceptional. More significantly, the hold-ups triggered by the pandemic developed a ton of suppressed demand. And that need is now going to be pressed into 2021. In truth, I forecast that more than 500 million 5G devices will be delivered in 2021 - diplomatic relations. And that's not my only 5G prediction When I've discussed 5G in the past, I have actually explained its three different phases.
In Phase 2, 5G gadgets go on sale. 5G phones and other products start to reach consumers. And in Phase Three, 5G services begin to be provided (genetic sequencer stock jeff brown). That's when we start to see applications running on 5G networks. Consider things like massive multiplayer games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will begin Phase Three by this summer. This starts something of a virtuous cycle: Many people don't actually appreciate the innovation. But they will care if there are amazing applications that can just be accessed with a 5G phone.
That causes more 5G apps being developed. In reality, 5G is going to open a suite of amazing applications: self-driving automobiles, the Internet of Things, robotic surgery, and more. All of these technologies need 5G. The investment chances going forward will be enormous. Stepping far from 5G, the next essential innovation I predict in 2021 is CRISPR genetic editing. CRISPR represents "clustered frequently interspaced brief palindromic repeat." It's a mouthful. But it's one of the most exciting developments in biotechnology. At a high level, CRISPR is a technology that can modify our genetic makeup as if it were software.
The program can crash or not work correctly. CRISPR uses a comparable idea however with our hereditary code. "Typos" in our genome can cause illness. CRISPR can fix these "typos." For several years, CRISPR was mainly a specific niche innovation that wasn't well comprehended. And during that time, there were actually just 3 business operating in this space. But things are changing. CRISPR is no longer simply theoretical. We're seeing actual results. We're treating diseases and seeing that this innovation just works. And as a result, a "second crop" of early-stage CRISPR business is going public and delivering amazing returns. This whole industry is successfully a greenfield chance.
There's space for many companies to exist in this space. social media. And there will be more. That's my forecast for CRISPR in 2021. I forecast that 2 or three more hereditary editing companies will hold their IPOs. Sticking with biotechnology, we are seeing remarkable things happening at the convergence of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its newest Alpha, Fold software application can precisely forecast the folding of a protein based exclusively on its amino acid series with 92. 4% precision. That's important since the method a protein in the human body folds determines if a pharmaceutical will be able to bind to that protein and be effective.
Historically, this has actually been a trial-and-error process. Today, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're created to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one but several drug therapies produced utilizing this innovation. This was one of those advancements that almost nobody observed. However it's going to have extensive implications for curing disease. And, naturally, there will be plenty of financial investment opportunities in this space, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be surprised if it drew back perhaps considerably prior to going higher. I have actually been covering bitcoin for a very long time now. Among the first research study reports I ever released was on bitcoin - tech predictions. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for anyone who followed my suggestion. But at the time of that preliminary recommendation, I entitled my report, "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time.
However no one is asking that concern any longer. Now, we're seeing institutional cash finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche business. second wave. Mass, Mutual is a 150-year-old institution. So think of that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus offer prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and declares the information depends on date since February 2021, but we might not separately confirm this claim. Offered Jeff Brown's past, he likely has a substantial net worth, but we can't hammer down an accurate figure at this moment. Brown is best known for his sage-like ability to select winning innovation stocks. He invested more than 25 years researching innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience gives him an exceptional viewpoint on the marketplace. He's constantly on the hunt for new opportunities, and he shares a number of his finest picks in the Future Report.
That's full marks, but it's not absurdly reasoned. Brown has an outstanding track record as a stock-picker, and he successfully anticipated some of the greatest financial occasions of the past 20 years. Although he does not appear to launch his choices to the general public, the service's success is a direct sign of Brown's stock-picking expertise. Nobody on Wall Street gets it best whenever, but Jeff Brown's precise forecasts have actually made him legions of dedicated fans. That says a lot about his ability. The Future Report is released by Brownstone Research, a prominent financial research publisher. Brownstone Research offers a number of research services with a variety of expertises - tech predictions.
The company is likewise affiliated with Bonner & Partners, another well-respected research study publisher - brownstone research stock. On its website, Brownstone states its mission is to provide retail investors with professional-grade research: "For too long, the best investment research study has actually not been offered to specific investors. It has actually been usually reserved for financial investment banks, hedge funds, private equity, and high-net-worth clients. the legacy report predictions. The mission of Brownstone Research study is to make that kind of exclusive research readily available to any investors seeking to acquire an edge in the markets. The goal is simple to deliver distinct and successful financial investment research study discovered nowhere else." -Brownstone Research website excerpt from the Jeff Brown is the creator of Brownstone Research study, and he also serves as the firm's Chief Investment Analyst.
With Brown directing the ship, Brownstone Research is a powerhouse publisher with lots to provide its customers. After decades of steady success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a home name throughout the majority of America. If you know even a bit about the market, you understand that he has a credibility as a King Midas of sorts. jeff brown predictions for 2021. Everything he touches relies on gold! Jeff is aware of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge project.
In reality, Brown thinks S.A.V. jeff brown biotech stock. could be "the biggest pattern of the 2020s, and he's not alone. Take a look at these quotes from other widely known S.A.V. bulls: Elon's next big act will be marrying 2 innovative technologies: synthetic intelligence and electric cars. Musk hopes the mix will assist him develop the very first fully-autonomous, self-driving vehicles ever. It's nothing brief of the automobile market's Holy Grail. As you understand, electric automobiles and self-driving vehicle stocks have actually been huge this year, but the Wall Street device has approved buzz without much tangible result. Despite a drastic increase in competitors over the previous couple of years, Brown still believes Musk has the very best opportunity of putting everything together.
tech might be the magic string that ties it all together. S.A.V. represents Shared Autonomous Automobile, and it might be the future of transport. Generally, this innovation would permit you to lease your car as an autonomous, self-driving taxi when you're not using it. You merely leave the vehicle and press a button on an app that tells the automobile to "join the fleet." Next thing you understand, you're relaxing on your couch while your vehicle shuttles ride-sharers around town. Best of all, you get to keep a large chunk of the earnings. It sounds outrageous, but it could be closed than you think.